Nurses, medical assistants, and front-desk staff call in, fax, and transmit controlled substance prescriptions every business day, and DEA's regulations draw a narrow line around what that staff member may do as the practitioner's agent. Under 21 CFR 1306, an agent may prepare a prescription and carry it to the pharmacy. An agent may not decide to issue it, and the registrant answers for the prescription's validity no matter who pressed send, picked up the phone, or sent the fax.
What an Agent May Prepare and Transmit
21 CFR 1306.05 lets "the secretary or agent" of a practitioner prepare a paper prescription for the practitioner's signature; the practitioner still has to review and sign it personally. Section 1306.11 extends that agency concept to delivery: a Schedule II prescription "may be transmitted by the practitioner or the practitioner's agent to a pharmacy via facsimile equipment," and Section 1306.21 extends the same agent-facsimile language to Schedule III through V. Electronic prescriptions follow a separate framework under 21 CFR part 1311, which requires the practitioner to authenticate and sign personally and bars sharing that credential with anyone else. In each task the regulation permits, the agent carries a signed decision the practitioner already made, not a request the agent communicates on its own authority. Controlled substance prescribing through a telehealth encounter raises the same agent question, with an added layer of prescriber-location rules covered in Telemedicine Controlled Substance Prescribing Rules.
What Only the Prescriber May Decide
The regulation's own wording keeps the prescribing decision with the practitioner. Its oral-authorization provision for Schedule II emergencies describes authorization "of a prescribing individual practitioner," and its oral-prescription provision for Schedule III through V describes an oral prescription "made by an individual practitioner," not by staff relaying a request on the practitioner's behalf. An agent who approves a refill, extends a quantity, or substitutes a drug because the prescriber is unavailable has stepped outside the agency the regulation describes. The line sits differently for a mid-level practitioner, who can hold independent, state-limited prescriptive authority of their own, a separate question covered in Mid-Level Practitioner Prescribing Authority Limits. An agent who is not a licensed prescriber has no prescriptive authority to lend, only the practitioner's authorization to carry.
Emergency Oral Authorization for Schedule II
Schedule II prescriptions get the strictest treatment because they carry the highest potential for diversion. In a genuine emergency, 21 CFR 1306.11(d) lets a pharmacist dispense on the oral authorization of the prescribing practitioner, then closes the loop fast: "within 7 days after authorizing an emergency oral prescription, the prescribing individual practitioner shall cause a written prescription for the emergency quantity prescribed to be delivered to the dispensing pharmacist." An agent can carry that follow-up document to the pharmacy or put it in the mail. The oral authorization itself, and the 7-day obligation that follows it, belong to the practitioner.
Liability Stays with the Registrant
21 CFR 1306.05 states the rule for every one of these scenarios in a single sentence: a prescription may be prepared by the secretary or agent for the practitioner's signature, "but the prescribing practitioner is responsible in case the prescription does not conform in all essential respects to the law and regulations." Delegating the paperwork does not delegate the registration. A phoned-in refill with the wrong days' supply or an unconfirmed quantity change can produce a prescription that does not hold up, and DEA looks to the registrant who signed it, not the staff member who sent it. That exposure can move from a corrective-action conversation to an order to show cause and, where DEA sees an immediate threat to public safety, an immediate suspension order that pulls the registration before a hearing takes place.
An agent can carry a controlled substance prescription to the pharmacy. Only the registrant answers for whether it was valid in the first place.
Why Early Legal Counsel Is Critical
It is critical that pharmacies and prescriber practices promptly retain experienced healthcare defense counsel once a DEA investigator or auditor begins asking who transmitted a specific controlled substance prescription and on what authority. Early legal intervention can review agent call logs and fax transmission records before they are produced, correct a delegation practice that exceeds 21 CFR 1306 before the next refill goes out, and position the registrant to respond to DEA's questions without conceding more than the facts require. Waiting until a show-cause notice arrives narrows the options for defending the registration.
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
Health Law Alliance's DEA defense attorneys review prescription-transmission practices, agent authorization policies, and prescriber-office call logs before a routine DEA inspection becomes a registration action. If your pharmacy or practice is facing questions about who transmitted a controlled substance prescription, contact HLA's DEA defense team for a free, confidential consultation.





